Industry

In Other News

• Ultrasensitive MRD Assay Gains Medicare Coverage for Immunotherapy and Breast Cancer Monitoring

• Genprex and Roche Collaborate on AI-Driven NSCLC Biomarker Testing

• Collaboration Explores Clinical Use of Single-Cell and Spatial Technologies

• Portable Point-of-Care Molecular Test Detects Lassa Fever in Real Time

• Partnership Brings Automated Pathology Archiving Solutions to U.S. Labs

• New Collaboration Integrates Low-Code Automation into Laboratory Platform

• ADLM 2026 Unites Laboratory Experts Around Emerging Diagnostic Technologies

• Blood Test Enters UK Primary Care Pathway for Earlier Alzheimer’s Diagnosis

• LumiQuick Advances Oxidative Stress Research with Expanded AOXRE Portfolio

• Collaboration Advances Sputum-Based Diagnostics for Asthma and COPD

• Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers

• Collaboration Advances Extracellular Vesicle-Based Tests for Neurodegenerative Diseases

• Tempus to Acquire Personalis in $1.5 Billion Precision Oncology Deal

• Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections

• Leica Biosystems to Expand Pathology Portfolio Through StatLab Acquisition

• Seed Amplification Test Expands Access to Neurodegenerative Disease Testing

• Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

• Eurobio Scientific Completes Acquisition of CareDx Lab Products Division

• Blood-Based CRISPR Test for Tuberculosis Gains Regulatory Approval in Colombia

• Partnership Integrates Automated DNA Extraction with Single-Molecule Digital PCR

• Agilent Strengthens Pathology Capabilities Through Biocare Acquisition

• Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio

• Project Aims to Develop First Single-Cell Assay for ADC Therapies